[Antagonists of the GPIIb/IIIa platelet receptor].
Gomes
M E
ME
Departamento de Farmacologia e Toxicologia, Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, Porto Alegre, RS.
Fabris
C
C
B filho
J L
JL
Dreher
R
R
Rosito
G A
GA
D000085:Acetates / Q000494:pharmacology; D001550:Benzamidines / Q000494:pharmacology; D001792:Blood Platelets / Q000502:physiology; D002318:Cardiovascular Diseases / Q000503:physiopathology; D002986:Clinical Trials as Topic; D006801:Humans; D010091:Oximes / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology
D000085:Acetates; D001550:Benzamidines; D010091:Oximes; D010880:Piperidines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; C084062:lamifiban; C091295:xemilofiban; C100917:sibrafiban